BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25105093)

  • 1. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
    Hammond E; Khurana A; Shridhar V; Dredge K
    Front Oncol; 2014; 4():195. PubMed ID: 25105093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SULFs in human neoplasia: implication as progression and prognosis factors.
    Bret C; Moreaux J; Schved JF; Hose D; Klein B
    J Transl Med; 2011 May; 9():72. PubMed ID: 21599997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan Sulfate in the Tumor Microenvironment.
    Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
    Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of heparan sulfate sulfation in dentinogenesis.
    Hayano S; Kurosaka H; Yanagita T; Kalus I; Milz F; Ishihara Y; Islam MN; Kawanabe N; Saito M; Kamioka H; Adachi T; Dierks T; Yamashiro T
    J Biol Chem; 2012 Apr; 287(15):12217-29. PubMed ID: 22351753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets.
    Han M; Zhu H; Chen X; Luo X
    Am J Cancer Res; 2024; 14(2):897-916. PubMed ID: 38455409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
    Nagarajan A; Malvi P; Wajapeyee N
    Front Endocrinol (Lausanne); 2018; 9():483. PubMed ID: 30197623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.
    De Pasquale V; Pavone LM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival.
    Holst CR; Bou-Reslan H; Gore BB; Wong K; Grant D; Chalasani S; Carano RA; Frantz GD; Tessier-Lavigne M; Bolon B; French DM; Ashkenazi A
    PLoS One; 2007 Jun; 2(6):e575. PubMed ID: 17593974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
    Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
    BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.
    Alshehri MA; Alshehri MM; Albalawi NN; Al-Ghamdi MA; Al-Gayyar MMH
    Oncol Lett; 2021 Feb; 21(2):173. PubMed ID: 33552290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2.
    Lum DH; Tan J; Rosen SD; Werb Z
    Mol Cell Biol; 2007 Jan; 27(2):678-88. PubMed ID: 17116694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.
    Maltseva I; Chan M; Kalus I; Dierks T; Rosen SD
    PLoS One; 2013; 8(8):e69642. PubMed ID: 23950901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Sulfatase Expression and Invasion in Glioblastoma.
    Wade A; Engler JR; Tran VM; Phillips JJ
    Methods Mol Biol; 2022; 2303():415-425. PubMed ID: 34626397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
    Cassinelli G; Zaffaroni N; Lanzi C
    Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
    Lamanna WC; Frese MA; Balleininger M; Dierks T
    J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.